Clinical Research Studies
DallasAllergyImmunology (DAI) has a mission to empower patients through education and research. Because of this mindset DAI offers their adult and pediatric patients the opportunity to participate in clinical research studies. These studies test safety and effectiveness of the latest pharmaceutical agents before and after these new medications reach the general public. DAI conducts FDA approved clinical research studies from Phases 1 to 4. These investigative studies are planned for improved treatment of asthma, allergic rhinitis, atopic dermatitis, immunodeficiency and other related problems.